NDC 0078-0743

ILEVRO

Nepafenac

ILEVRO is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Nepafenac.

Product ID0078-0743_0cb21156-4f4a-4e49-bc0c-7d2eab045f86
NDC0078-0743
Product TypeHuman Prescription Drug
Proprietary NameILEVRO
Generic NameNepafenac
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2012-12-20
Marketing CategoryNDA / NDA
Application NumberNDA203491
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameNEPAFENAC
Active Ingredient Strength3 mg/mL
Pharm ClassesAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0078-0743-03

1 BOTTLE in 1 CARTON (0078-0743-03) > 3 mL in 1 BOTTLE
Marketing Start Date2021-01-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ILEVRO" or generic name "Nepafenac"

NDCBrand NameGeneric Name
0065-1750ILEVROnepafenac
0078-0743ILEVROnepafenac
0065-0002NEVANACnepafenac
0078-0778NEVANACnepafenac

Trademark Results [ILEVRO]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ILEVRO
ILEVRO
85716211 4397658 Live/Registered
Novartis AG
2012-08-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.